It’s still open season for bio-piracy
Rich nations block accord on benefit-sharing rules for the world’s genetic resources
Gunning for green tech
US continues to target India over its intellectual property regime, especially in pharma, green tech sectors
Crazy GM patent system
The Brazilian lawsuit against Monsanto’s royalty on soybean seeds exposes the irrational way in which laws apply to GM crops
Righting the copywrong
Amending the Copyright Act to give directors, composers and musicians rights over their work has corrected a historic wrong but trouble is brewing
Choking access to drugs
Drug prices are likely to increase as rich countries and their pharma companies squeeze Indian generics out of the market. How can India’s …
Patent hypocrisies of US
American business lobbies are spreading falsehoods about India’s patent policies—and glossing over their double standards
Any cheers for Doha pact?
The Doha Declaration on protecting public health is a decade old, but developing countries have not been able to make use of TRIPs flexibilities
Drug affordability test
Natco’s bid for a compulsory licence to manufacture a Bayer anti-cancer drug is a test of the law’s ‘reasonable price’ …
No climate for cleantech
Most of the clean energy innovations are with just six rich countries and hardly any technology is coming to developing nations
A pre-emptive strike against Monsanto
American organic farmers are trying to ensure the biotech giant cannot sue them
Bringing Google to book
Google’s digital library project went too far, creating a monopoly over the heritage of books
The curious case of Ebola patents
The US government appears to have a cure and (almost) a vaccine for the deadly disease
Patent issues delaying Ebola cure
Canada's exclusive licensing rights of its Ebola patent to a US firm are holding up global development of a vaccine
What Durban did not discuss
IPRs are blocking access to mitigation and adaptation technologies. India offers a way out
New endosulfan ploy
Industry is sidestepping issues by pitching the proposed UN ban on endosulfan as the battle between generics and patented pesticides
Predatory EU pacts
EU is pushing India and Canada to sign free trade agreements that will hurt their generic drugs—and the outrage is global
WTO gives India a clean chit
Apex trade regulator finds nothing amiss in India's intellectual property laws after exhaustive review
Biotech industry has a new patron
Department of Biotechnology is playing venture capitalist to private companies to push biotech research in agriculture
Testing the CL route
Roche’s Herceptin will be a test case for government and generics industry as India readies to issue compulsory licences for life-saving drugs
The Avon lady lifts our biodiversity
Loopholes in the Biological Diversity Act being used to export India’s genetic material
ICAR chases patents for pickle
The National Research Centre on Meat has odd ideas on what can be patented
‘PESTICIDES’ IN DRUGS
Sharad Pawar’s provision for protecting test data in the Pesticides Bill could spill over into trade agreements and hit the drugs industry, too
US pharma strikes back
Upset by the Supreme Court’s endorsement of India’s patent law, the American drug industry is lobbying with Obama to tighten the …
Trail of a $500 m gene
How a rare African algae collected by a French academic turns into a commercial bonanza for an equity firm in Hong Kong. Are there any benefits …
A treaty too many
India is learning that there is a heavy price to be paid for the large number of bilateral investment treaties, or BITs, it has signed in the …